摘要
脊髓损伤(SCI)是一种常见的神经功能障碍性疾病,它将导致感官功能和移动性的丧失。组织工程学是一个潜在的治疗脊髓损伤的治疗策略,这是有据可查的。在这一点上,各种各样的生物材料已经被开发出来以满足脊髓损伤组织工程的需要,这包括天然材料,合成生物降解高分子和合成非降解聚合物。纳米纤维支架是最近新兴的被广泛应用于组织工程的生物材料。与传统的生物材料相比,纳米纤维在拓扑结构和孔隙率方面具有优势,从而能够模仿天然细胞外基质。另外,它们显示了极好的生物相容性和低的免疫原性,此外它们具有能够帮助弥合病变腔或者孔隙的特性,且可作为移植细胞或者治疗药物的一种有效的运输递质系统。这篇综述总结了在治疗脊髓损伤方面具有至关重要的潜在应用的纳米纤维支架的一些独特的属性。
关键词: 生物相容性,静电纺丝,纳米纤维支架,神经元再生,相位分离,自组装多肽,脊髓损伤,组织工程学,拓扑结构
Current Medicinal Chemistry
Title:Nanofiber Scaffolds for Treatment of Spinal Cord Injury
Volume: 21 Issue: 37
Author(s): Jia-Song Guo, Chang-Hui Qian, Eng-Ang Ling and Yuan-Shan Zeng
Affiliation:
关键词: 生物相容性,静电纺丝,纳米纤维支架,神经元再生,相位分离,自组装多肽,脊髓损伤,组织工程学,拓扑结构
摘要: Spinal cord injury (SCI) is a common neurologic disorder that results in loss of sensory function and mobility. It is well documented that tissue engineering is a potential therapeutic strategy for treatment of SCI. In this connection, various biomaterials have been explored to meet the needs of SCI tissue engineering and these include natural materials, synthetic biodegradable polymers and synthetic non- degradable polymers. Nanofiber scaffolds are newly emerging biomaterials that have been widely utilized in tissue engineering recently. In comparison to the traditional biomaterials, nanofibers have advantages in topography and porosity, thus mimicking the naturally occurring extracellular matrix. Besides, they exhibit excellent biocompatibility with low immunogenicity, and furthermore they are endowed with properties that help to bridge the lesion cavity or gap, and serve as an effective delivery system for graft cells or therapeutic drugs. This review summarizes some of the unique properties of nanofiber scaffolds which are critical to their potential application in treatment of injured spinal cord.
Export Options
About this article
Cite this article as:
Guo Jia-Song, Qian Chang-Hui, Ling Eng-Ang and Zeng Yuan-Shan, Nanofiber Scaffolds for Treatment of Spinal Cord Injury, Current Medicinal Chemistry 2014; 21 (37) . https://dx.doi.org/10.2174/0929867321666140815124648
DOI https://dx.doi.org/10.2174/0929867321666140815124648 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Subject Index to Volume 3
Current Drug Targets - CNS & Neurological Disorders Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets n-3 Fatty Acids: Role in Neurogenesis and Neuroplasticity
Current Medicinal Chemistry Fire Needle Acupuncture Regulates Wnt/ERK Multiple Pathways to Promote Neural Stem Cells to Differentiate into Neurons in Rats with Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Patent Selections:
Recent Patents on Regenerative Medicine Autoantibodies in Autoimmune Diseases
Current Pharmaceutical Design Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism Synthesis, Evaluation of Analgesic and Gastric Ulcerogenic Activities and the Metabolites in Rat Plasma of Hydantoin Ibuprofen Conjugates
Letters in Drug Design & Discovery In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Current Concepts in the Understanding of Pain in the Rheumatic Diseases
Current Rheumatology Reviews Pharmacological Neuroprotection in Cardiac Surgery: Effectiveness of Pharmacologic-Preconditioning with Erythromycin
Current Vascular Pharmacology Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications
CNS & Neurological Disorders - Drug Targets Pro- and Anti-Arrhythmic Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
Current Pediatric Reviews Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
CNS & Neurological Disorders - Drug Targets Medical Applications of Collagen and Collagen-Based Materials
Current Medicinal Chemistry